Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, autosomal dominant disorder caused by mutation in the SCN11A gene. It is characterized by intense episodic pain mainly affecting the distal lower extremities in early childhood. The pain diminishes with age.
Features include common findings: Problems with involuntary body functions (abnormal autonomic nervous system physiology). 2 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 2 | Problems with involuntary body functions (abnormal autonomic nervous system physiology), Pain |
SCN11A function has not been fully characterized.
Familial episodic pain syndrome with predominantly lower limb involvement is associated with mutations in the SCN11A gene on chromosome 3.
Genetic testing for SCN11A is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for familial episodic pain syndrome with predominantly lower limb involvement has been reported in the published literature.
Phenotype severity distribution: 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for familial episodic pain syndrome with predominantly lower limb involvement.
34 publications have been identified in PubMed for familial episodic pain syndrome with predominantly lower limb involvement. Research spans Case Report / Case Series (41%), Epidemiology / Natural History (16%), and Diagnostic / Biomarker (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 13 | 41% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:41 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
5 |
16% |
Testing and diagnosis research | 4 | 13% |
Research summaries | 4 | 13% |
Clinical study results | 3 | 9% |
Other research | 2 | 6% |
Laboratory research | 1 | 3% |
Xiong LY (2026). [PMID: 41674423](https://pubmed.ncbi.nlm.nih.gov/41674423/). *Zhonghua Er Ke Za Zhi*. [Diagnostic / Biomarker]
Dai Q (2026). [PMID: 41927091](https://pubmed.ncbi.nlm.nih.gov/41927091/). *Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi*. [Diagnostic / Biomarker]
Musayeva G (2026). [PMID: 41857576](https://pubmed.ncbi.nlm.nih.gov/41857576/). *Orphanet J Rare Dis*. [Diagnostic / Biomarker]
Loomba R (2026). [PMID: 41923352](https://pubmed.ncbi.nlm.nih.gov/41923352/). *Aliment Pharmacol Ther*. [Clinical Trial Publication]
Unknown (2026). [PMID: 42160649](https://pubmed.ncbi.nlm.nih.gov/42160649/). *Unknown Journal*. [Review / Meta-Analysis]
Kurihara M (2026). [PMID: 40571583](https://pubmed.ncbi.nlm.nih.gov/40571583/). *J Nippon Med Sch*. [Case Report / Case Series]
Das M (2026). [PMID: 41651562](https://pubmed.ncbi.nlm.nih.gov/41651562/). *Open Heart*. [Epidemiology / Natural History]
Bureychak T (2025). [PMID: 40851371](https://pubmed.ncbi.nlm.nih.gov/40851371/). *Neurogastroenterol Motil*. [Review / Meta-Analysis]
Devigili G (2025). [PMID: 40772640](https://pubmed.ncbi.nlm.nih.gov/40772640/). *Curr Opin Neurol*. [Review / Meta-Analysis]
Chen YJ (2025). [PMID: 39737520](https://pubmed.ncbi.nlm.nih.gov/39737520/). *Neurogastroenterol Motil*. [Epidemiology / Natural History]